We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+8.99%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$21.9B
AUM Growth
+$21.9B
Cap. Flow
-$417M
Cap. Flow %
-1.9%
Top 10 Hldgs %
13.08%
Holding
3,337
New
135
Increased
1,103
Reduced
1,007
Closed
163

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$89.3M
2
KEYS icon
Keysight
KEYS
+$86M
3
NKE icon
Nike
NKE
+$78.3M
4
APH icon
Amphenol
APH
+$76.5M
5
CMCSA icon
Comcast
CMCSA
+$72.3M

Top Sells

Rank Stock Value
1
CE icon
Celanese
CE
+$108M
2
MNST icon
Monster Beverage
MNST
+$97.8M
3
SBUX icon
Starbucks
SBUX
+$79.7M
4
TXN icon
Texas Instruments
TXN
+$67.3M
5
CNC icon
Centene
CNC
+$64.3M

Sector Composition

Rank Sector Weight
1 Technology 18.83%
2 Financials 13.42%
3 Healthcare 13.25%
4 Industrials 9.77%
5 Consumer Discretionary 7.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VISN
1351
Vistance Networks Inc
VISN
$2.67B
$57K ﹤0.01%
4,059
ELME
1352
Elme Communities
ELME
$142M
$57K ﹤0.01%
1,966
+238
+14% +$7.07K
MRVL icon
1353
Marvell Technology
MRVL
$157B
$57K ﹤0.01%
2,200
UAA icon
1354
Under Armour
UAA
$3.04B
$57K ﹤0.01%
2,682
-677
-20% -$13.1K
CORR
1355
DELISTED
CorEnergy Infrastructure Trust, Inc.
CORR
$57K ﹤0.01%
1,280
ALK icon
1356
Alaska Air
ALK
$5.42B
$56K ﹤0.01%
840
-74
-8% -$5.05K
BAP icon
1357
Credicorp
BAP
$30.9B
$56K ﹤0.01%
264
-10
-4% -$2.1K
CHIQ icon
1358
Global X MSCI China Consumer Discretionary ETF
CHIQ
$128M
$56K ﹤0.01%
3,080
EDIT icon
1359
Editas Medicine
EDIT
$402M
$56K ﹤0.01%
1,927
-818
-30% -$20.4K
NKTR icon
1360
Nektar Therapeutics
NKTR
$2.39B
$56K ﹤0.01%
176
KYO
1361
DELISTED
Kyocera Adr
KYO
$56K ﹤0.01%
823
+136
+20% +$9.25K
FNM.PRS
1362
DELISTED
FEDERAL NATIONAL MORTGAGE ASSOCIATION PFD SER S (USA)
FNM.PRS
$56K ﹤0.01%
4,700
-800
-15% -$9.53K
ARE icon
1363
Alexandria Real Estate Equities
ARE
$9.41B
$55K ﹤0.01%
344
+218
+173% +$34.4K
CTRA
1364
DELISTED
Coterra Energy
CTRA
$55K ﹤0.01%
3,183
PAG icon
1365
Penske Automotive Group
PAG
$14.5B
$55K ﹤0.01%
1,121
RF.PRB
1366
DELISTED
REGIONS FINANCIAL CORPORATION
RF.PRB
$55K ﹤0.01%
1,965
IGRO icon
1367
iShares International Dividend Growth ETF
IGRO
$1.29B
$54K ﹤0.01%
899
MDB icon
1368
MongoDB
MDB
$25B
$54K ﹤0.01%
411
-328
-44% -$43.1K
NRG icon
1369
NRG Energy
NRG
$26.9B
$54K ﹤0.01%
1,382
TLK icon
1370
Telkom Indonesia
TLK
$14.2B
$54K ﹤0.01%
1,900
RVNC
1371
DELISTED
Revance Therapeutics, Inc.
RVNC
$54K ﹤0.01%
3,382
-68
-2% -$1.05K
AVAL icon
1372
Grupo Aval
AVAL
$5.79B
$53K ﹤0.01%
6,147
DBEF icon
1373
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
$9.16B
$53K ﹤0.01%
1,584
IMO icon
1374
Imperial Oil
IMO
$60.8B
$53K ﹤0.01%
2,033
-200
-9% -$5.06K
IOSP icon
1375
Innospec
IOSP
$2.12B
$53K ﹤0.01%
521
+83
+19% +$7.94K

Similar funds

Glenmede Trust's Q4 2019 Portfolio in Review

As of Q4 2019, Glenmede Trust held 3,337 positions worth $21.9B, up 100,205% from $21.9M the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Glenmede Trust's Q4 2019 filing shows 135 new, 1,103 increased, 1,007 reduced and 163 closed positions. Its largest new stake was Callon Petroleum Company: 285,674 shares worth $13.8M. The largest sale was Celanese, an estimated $108M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • Glenmede Trust's largest Q4 2019 buy was Callon Petroleum Company: 285,674 shares worth $13.8M.
  • Glenmede Trust added most to Bristol-Myers Squibb in Q4 2019, an estimated $89.3M increase.
  • Glenmede Trust's biggest Q4 2019 reduction was Celanese, cutting an estimated $108M.
  • Glenmede Trust fully exited Celgene Corp in Q4 2019, selling an estimated $122K.
  • Glenmede Trust's ten largest holdings make up 13% of its $21.9B portfolio in Q4 2019.
  • Glenmede Trust opened 135 new positions and closed 163 in Q4 2019.
  • Glenmede Trust's portfolio value rose 100,205% quarter-over-quarter to $21.9B.

Based on Glenmede Trust's 13F filing for Q4 2019, filed 12 Feb 2020.